Rubraca 300 mg film-coated tablets, Rubraca 200 mg film-coated tablets, BEVACIZUMAB, Rubraca 250 mg film-coated tablets, CARBOPLATIN, PACLITAXEL
MITO 25.1
Phase 2 small_molecule active
Quick answer
Rubraca 300 mg film-coated tablets, Rubraca 200 mg film-coated tablets, BEVACIZUMAB, Rubraca 250 mg film-coated tablets, CARBOPLATIN, PACLITAXEL for Advanced (stage III B-C-IV) ovarian, primary peritoneal and Fallopian tube cancer. is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Advanced (stage III B-C-IV) ovarian, primary peritoneal and Fallopian tube cancer.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active